Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision...

Area of Science:

• Cardiology
• Immunology
• Cell Biology

Background:

• Cardiac fibrosis significantly contributes to heart failure, impacting a growing patient population globally.
• Cardiovascular comorbidities can worsen cardiac fibrosis.
• While fibroblasts are traditionally implicated, other cell types also influence fibrotic processes.

Purpose of the Study:

• To provide a comprehensive overview of the molecular and cellular mechanisms driving cardiac tissue fibrosis.
• To outline current diagnostic tools and contemporary clinical treatment strategies for cardiac fibrosis.
• To highlight the role of the immune microenvironment in cardiac fibrosis pathogenesis.

Main Methods:

• Review of existing literature on molecular and cellular mechanisms of cardiac fibrosis.
• Analysis of diagnostic approaches for cardiac fibrosis.
• Summary of current therapeutic strategies for cardiac fibrosis.
• Exploration of the immune microenvironment's role in cardiac fibrosis.

Main Results:

• Cardiac fibrosis is a complex process involving multiple cell types beyond fibroblasts.
• The immune microenvironment plays a critical role in the development and progression of cardiac fibrosis.
• Despite therapeutic advancements, clinical outcomes for heart failure patients remain a challenge.

Conclusions:

• A deeper understanding of cardiac fibrosis mechanisms, including non-fibroblast cell involvement and immune interactions, is essential.
• Integrated approaches combining diagnostics and therapeutics targeting the immune microenvironment may improve patient outcomes.
• Further research is needed to translate mechanistic insights into improved clinical management of heart failure due to cardiac fibrosis.